Cours China Medical System Inc. Other OTC

Actions

31/01	Tyligand Bioscience Limited announced that it has received $32 million in funding from China Medical System Inc., Shanghai Fanyi Biotechnology Partnership Enterprise (Limited Partnership), Shanghai Shengdi Private Equity Fund Management Co., Ltd., Tencent Mobility Limited and other investors
21/05/21	Tyligand Bioscience Shanghai Limited announced that it has received $20.000000 million in funding from China Medical System Inc., Yijing Capital and another investor.

1 jour

-16,67 %

Employés

Secteur